Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Amazonian Cinnamon (Ocotea quixos), commonly known as ishpingo, is a Lauraceae-family tree native to the Ecuadorian Amazon whose bark is rich in trans-cinnamaldehyde, methyl cinnamate, and 1,8-cineole—compounds that inhibit NF-κB-mediated inflammatory signaling and activate the Nrf2 antioxidant pathway. While no dedicated clinical trials on O. quixos appear in PubMed, its cinnamaldehyde content parallels well-studied Cinnamomum species shown to improve insulin sensitivity, lower fasting blood glucose, and reduce LDL cholesterol in human trials.
Reported Benefits (Provisional)
Origin & History
Amazonian Cinnamon, derived from various *Cinnamomum* species native to the Amazon rainforest, is a distinct botanical with a rich history in indigenous traditions. It is valued for its unique profile of cinnamaldehyde and polyphenols, offering significant benefits for metabolic, cardiovascular, and cognitive health.
Research Narrative (Provisional)
No species-specific PubMed clinical trials on Ocotea quixos (Amazonian Cinnamon / ishpingo) have been published to date, making direct citation of controlled human studies impossible at this time. However, phytochemical analyses have confirmed that the bark and leaves of O. quixos contain trans-cinnamaldehyde (up to 45% of essential oil composition), methyl cinnamate, and 1,8-cineole, overlapping significantly with bioactive profiles of Cinnamomum verum and C. cassia that have been extensively studied. Broader cinnamon research—including meta-analyses of randomized controlled trials—demonstrates that cinnamaldehyde-rich extracts can reduce fasting blood glucose by 24.59 mg/dL and lower LDL cholesterol. Rigorous human clinical trials specifically on Amazonian Cinnamon are needed to confirm whether its traditional Amazonian medicinal applications translate into clinically validated outcomes.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Cinnamaldehyde: Key bioactive compound for metabolic and anti-inflammatory effects. - Polyphenols, Flavonoids, Tannins: Potent antioxidants and anti-inflammatory agents. - Essential Oils, Terpenes: Contribute to aromatic profile and therapeutic properties.
Reported Mechanism (Provisional)
Trans-cinnamaldehyde, the primary bioactive compound in Amazonian Cinnamon bark, suppresses the NF-κB and AP-1 transcription factor pathways by inhibiting IκB kinase (IKK) phosphorylation, thereby reducing expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Simultaneously, cinnamaldehyde activates the Keap1-Nrf2-ARE signaling axis, upregulating phase II detoxification enzymes such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferase (GST), conferring potent antioxidant cytoprotection. Regarding glucose metabolism, cinnamaldehyde enhances insulin receptor substrate-1 (IRS-1) phosphorylation and stimulates GLUT4 translocation to the cell membrane in skeletal muscle and adipose tissue, improving peripheral glucose uptake. Additional constituents including methyl cinnamate and polyphenolic proanthocyanidins contribute to α-glucosidase and α-amylase inhibition, delaying carbohydrate digestion and postprandial glycemic spikes.
Clinical Narrative (Provisional)
Current evidence for Amazonian Cinnamon is primarily based on preclinical in vitro and animal studies, with limited human clinical trials available. In rat Parkinson's models, cinnamon extracts increased striatal dopamine by 17-49% and reduced oxidative stress markers by 15-22%. Antioxidant studies show IC50 values of 1.771 mg/mL for DPPH and 0.060 mg/mL for ABTS radical scavenging. Human clinical trials are needed to validate these preclinical findings and establish therapeutic dosages.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.